Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07034508
What this trial is testing

A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 134
Not applicableEnded earlyNCT04688749
What this trial is testing

Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage

Who this might be right for
Melanoma (Skin)Basal Cell CarcinomaSquamous Cell Carcinoma+5 more
Aristotle University Of Thessaloniki 50
Not applicableStudy completedNCT00339326
What this trial is testing

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

Who this might be right for
Kaposi's Sarcoma
National Cancer Institute (NCI) 1,383
Large-scale testing (Phase 3)UnknownNCT04741438
What this trial is testing

Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype

Who this might be right for
Sarcoma
Centre Leon Berard 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT02790515
What this trial is testing

Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 170
Not applicableActive Not RecruitingNCT03077178
What this trial is testing

Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over

Who this might be right for
Soft Tissue Sarcoma Adult
Institut Bergonié 25
Testing effectiveness (Phase 2)Study completedNCT00055952
What this trial is testing

Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor

Who this might be right for
Sarcoma
Daiichi Sankyo
Testing effectiveness (Phase 2)Temporarily pausedNCT04824352
What this trial is testing

Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory Osteosarcoma

Who this might be right for
Effect of DrugToxicity, Drug
Peking University People's Hospital 44
Testing effectiveness (Phase 2)Study completedNCT02300545
What this trial is testing

Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy

Who this might be right for
Sarcoma, Soft TissueSoft Tissue Sarcoma
Washington University School of Medicine 56
Early research (Phase 1)WithdrawnNCT05905341
What this trial is testing

Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.

Who this might be right for
Breast CancerOvarian CancerLiposarcoma+3 more
Pfizer
Early research (Phase 1)Study completedNCT00623831
What this trial is testing

Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen

Who this might be right for
MelanomaSarcomaGastrointestinal Stromal Tumor (GIST)+6 more
Ludwig Institute for Cancer Research 17
Testing effectiveness (Phase 2)Ended earlyNCT00859456
What this trial is testing

Sunitinib in Certain Subtypes of Soft Tissue Sarcomas

Who this might be right for
Sarcoma, Soft Tissue
Columbia University 10
Large-scale testing (Phase 3)Looking for participantsNCT03805022
What this trial is testing

Benefit of Intensified Peri-operative Chemotherapy Within High-risk CINSARC Patients With Resectable Soft-tissue Sarcomas

Who this might be right for
Non-metastatic Soft-tissue SarcomaResectable
Institut Bergonié 351
Testing effectiveness (Phase 2)Study completedNCT01848457
What this trial is testing

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Who this might be right for
OsteosarcomaNephrotoxicityOtotoxicity
Children's Hospital of Philadelphia 13
Not applicableStudy completedNCT00919269
What this trial is testing

Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma

Who this might be right for
Adult RhabdomyosarcomaChildhood Desmoplastic Small Round Cell TumorChordoma+13 more
Children's Oncology Group 150
Not applicableEnded earlyNCT00615329
What this trial is testing

Huntsman Biopsy Study

Who this might be right for
Soft Tissue SarcomaOsteosarcoma
State University of New York - Upstate Medical University 142
Early research (Phase 1)UnknownNCT03076372
What this trial is testing

A Study Evaluating MM-310 in Patients With Solid Tumors

Who this might be right for
Solid TumorsUrothelial CarcinomaGastric Carcinoma+9 more
Merrimack Pharmaceuticals 34
Not applicableLooking for participantsNCT04132895
What this trial is testing

ICONIC: Improving Outcomes Through Collaboration in OsteosarComa

Who this might be right for
Osteosarcoma
University College, London 300
Early research (Phase 1)WithdrawnNCT03612466
What this trial is testing

A Dose Finding Study of CycloSam® Combined With External Beam Radiotherapy

Who this might be right for
OsteosarcomaBone Metastases
Albert Einstein College of Medicine
Not applicableStudy completedNCT03800121
What this trial is testing

Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)

Who this might be right for
Sarcoma
Centre Georges Francois Leclerc 34
Next Page